Institute for Health Metrics and Evaluation

Data cited: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years 1990-2016. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018.   The Global Burden of Disease Study 2016 (GBD 2016), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 195 countries and territories and at the subnational level for a subset of countries. Estimates for deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), years of life lost (YLLs), prevalence, and incidence for 29 cancer groups by age and sex for 1990-2016 are available from the GBD Results Tool. Files available in this record are the web tables published in JAMA Oncology in June 2018 in "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 29 Cancer Groups, 1990 to 2016."

The Global Burden of Disease Study 2015 (GBD 2015), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors at the global, regional, national, territorial, and, for a subset of countries, subnational level. This dataset measures progress towards the Millennium Development Goal 5 (MDG 5) target of a 75% reduction in the maternal mortality ratio between 1990 and 2015. Maternal mortality ratio estimates for 21 regions, 195 countries and territories and 4 United Kingdom subnational units for 1990-2015 (quinquennial) are available by age and cause from the GBD Results Tool. Files available in this record include tables published in The Lancet in October 2016 in "Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.

The Global Burden of Disease Study 2015 (GBD 2015), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors at the global, regional, national, territorial, and, for a subset of countries, subnational level. As part of this study, estimates for obesity and overweight prevalence and the disease burden attributable to high body mass index (BMI) were produced by sex, age group, and year for 195 countries and territories. Estimates for high BMI-attributable deaths, DALYs, and other measures (1990-2015) are available from the GBD Results Tool. Files available in this record include obesity and overweight prevalence estimates for 1980-2015. Study results were published in The New England Journal of Medicine in June 2017 in "Health Effects of Overweight and Obesity in 195 Countries over 25 Years."

Global Burden of Disease Study 2016 (GBD 2016) Healthcare Access and Quality Index Based on Amenable Mortality 1990–2016. Global Burden of Disease Study 2016 (GBD 2016) estimates were used in an analysis of personal healthcare access and quality for 195 countries and territories, as well as selected subnational locations, over time. This dataset includes the following global, regional, national, and selected subnational estimates for 1990-2016: age-standardized risk-standardized death rates from 24 non-cancer causes considered amenable to healthcare; age-standardized mortality-to-incidence ratios for 8 cancers considered amenable to healthcare; and the Healthcare Access and Quality (HAQ) Index and individual scores for each of the 32 causes on a scale of 0 to 100. Code used to produce the estimates is also included. Results were published in The Lancet in May 2018 in "Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

In December 2022, IHME paused its COVID-19 modeling. IHME has developed projections for total and daily deaths, daily infections and testing, hospital resource use, and social distancing due to COVID-19 for a number of countries. Forecasts at the subnational level are included for select countries. The projections for total deaths, daily deaths, and daily infections and testing each include a reference scenario: Current projection, which assumes social distancing mandates are re-imposed for 6 weeks whenever daily deaths reach 8 per million (0.8 per 100k). They also include two additional scenarios: Mandates easing, which reflects continued easing of social distancing mandates, and mandates are not re-imposed; and Universal Masks, which reflects 95% mask usage in public in every location. Hospital resource use forecasts are based on the Current projection scenario. Social distancing forecasts are based on the Mandates easing scenario. These projections are produced with a model that incorporates data on observed COVID-19 deaths, hospitalizations, and cases, information about social distancing and other protective measures, mobility, and other factors. They include uncertainty intervals and are being updated daily with new data. These forecasts were developed in order to provide hospitals, policy makers, and the public with crucial information about how expected need aligns with existing resources, so that cities and countries can best prepare. Dataset contains Observed and Projected data

Data cited at: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Socio-Demographic Index (SDI) 1950–2019. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020.